Dave Lennon was chosen by Novartis to run AveXis. Says they honestly havent internally finalized they price yet. PLW2019pic.twitter.com6cBTDoz089
Dave Lennon was chosen by Novartis to run AveXis. Says they honestly haven’t internally finalized they price yet. #PLW2019pic.twitter.com/6cBTDoz089
More From BioPortfolio on "Dave Lennon was chosen by Novartis to run AveXis. Says they honestly haven’t internally finalized they price yet. #PLW2019pic.twitter.com/6cBTDoz089"